Scientists at the Centre for Genomic Regulation (CRG), part of the Barcelona Institute of Science and Technology (BIST), in Barcelona, Spain, have uncovered the biological details of how cells produce a crucial molecule involved ...
Apr 2, 2019
0
2
Canadian researchers, working in partnership with Brazilian colleagues, have developed 13 bioluminescence sensors for use in testing the effectiveness of new medical drugs in the laboratory. The study, published in the journal ...
Mar 4, 2019
0
27
Mesenchymal stem cells (MSCs) are a promising cell source, easy to harvest and differentiate into a variety of mesodermal tissues including fat, bone and cartilage in regenerative medicine. However, for in vivo implantation, ...
Researchers know that the epigenome plays a key role in how DNA is expressed, and have linked changes in the epigenome to a wide variety of health problems – from cancers to autoimmune disorders. But not only is there a ...
Aug 30, 2018
0
11
UMBC researchers report novel method to quickly make therapeutic proteins from human blood
Jun 22, 2018
0
0
A new study from Chalmers University of Technology, Sweden, shines more light on the link between consumption of fish and better long-term neurological health. Parvalbumin, a protein found in great quantities in several fish ...
Apr 23, 2018
0
1322
mRNA drugs offer a promising new approach to deliver therapeutic replacement proteins, and novel strategies designed to engineer more stable and active proteins are further enhancing the potential of mRNA therapies. Specific ...
Mar 30, 2018
0
5
A new study has shown that heparan sulfate, a desirable natural material for use in bioengineered tissues and orthotic implants, can withstand the stress of gamma irradiation for sterilization and retain its structure, binding ...
Jan 25, 2018
0
2
Macquarie University researchers have discovered that a naturally occurring protein in the body protects the eye from the common eye disease glaucoma, and which is particularly sensitive to oxidation through environmental ...
Sep 27, 2017
0
101
A new hybrid molecule developed in the lab at the NYU Tandon School of Engineering shows promise for treating breast cancer by serving as a "shipping container" for cytotoxic—or cell-destroying—chemotherapeutic agents. ...
Apr 1, 2016
0
106
